MolecularMD and Mayo Clinic Enter Into Sub-License Agreement
MolecularMD Corp announced that it has granted a sub-license agreement for the detection of ABL kinase mutations in Chronic Myelogenous Leukemia (CML) patients to the Mayo Clinic.
Read More